The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug
- 1 August 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 35 (4), 379-395
- https://doi.org/10.1016/0049-3848(84)90230-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Ligand binding to thromboxane receptors on human platelets: correlation with biological activityBritish Journal of Pharmacology, 1983
- ANTAGONISM OF THE THROMBOXANE‐SENSITIVE CONTRACTILE SYSTEMS OF THE RABBIT AORTA, DOG SAPHENOUS VEIN AND GUINEA‐PIG TRACHEABritish Journal of Pharmacology, 1982
- Antiplatelet actions of trimetoquinol isomers: evidence for inhibition of a prostaglandin-independent pathway of platelet aggregationBiochemical Pharmacology, 1982
- Stereo-dependent inhibition of human platelet function by the optical isomers of trimetoquinolBiochemical Pharmacology, 1981
- COMPARISON OF THE ACTIONS OF U‐46619, A PROSTAGLANDIN H2‐ANALOGUE, WITH THOSE OF PROSTAGLANDIN H2 AND THROMBOXANE A2 ON SOME ISOLATED SMOOTH MUSCLE PREPARATIONSBritish Journal of Pharmacology, 1981
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThrombosis Research, 1980
- Estimation of thrombus formation by labeling of platelets, red cells and fibrinogen in experimental thrombosisThrombosis Research, 1979
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- Radioimmunoassay of Prostaglandins Fα, E1 and E2 in Human PlasmaEuropean Journal of Clinical Investigation, 1975
- Arachidonic Acid Causes Sudden Death in RabbitsScience, 1974